Skip to main content
SpringerLink
Log in

Introduction

  • Protocol
  • First Online:
Clinical Trials in Neurology

Part of the book series: Neuromethods ((NM,volume 138))

  • 619 Accesses

Abstract

This book chapter discusses the main methodological and regulatory aspects of clinical research, guiding future investigators to conduct valuable, innovative, and appropriate trials. As clinical research has the main goal of generating knowledge to the medical field and advancing diagnostic/therapeutic methods, understanding essential concepts and foundations of clinical research is essential for improving the field. Therefore, important topics such as study population, trial outcomes, design, statistical analysis, and ethical aspects are contemplated in this chapter. As the neurology field is the focus of this book, practical examples on neurological disorders are also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Umscheid CA, Margolis DJ, Grossman CE (2011) Key concepts of clinical trials: a narrative review. Postgrad Med 123:194–204

    Article  PubMed  PubMed Central  Google Scholar 

  2. Röhrig B, du Prel J-B, Blettner M (2009) Study design in medical research: part 2 of a series on the evaluation of scientific publications. Dtsch Arztebl Int 106:184–189

    PubMed  PubMed Central  Google Scholar 

  3. Carlson MDA, Morrison RS (2009) Study design, precision, and validity in observational studies. J Palliat Med 12:77–82

    Article  PubMed  PubMed Central  Google Scholar 

  4. Schulz KF, Grimes DA (2006) The Lancet handbook of essential concepts in clinical research. Elsevier, Amsterdam

    Google Scholar 

  5. Evans SR (2010) Clinical trial structures. J Exp Stroke Transl Med 3:8–18

    Article  PubMed  PubMed Central  Google Scholar 

  6. Christensen E (2007) Methodology of superiority vs. equivalence trials and non-inferiority trials. J Hepatol 46:947–954

    Article  PubMed  Google Scholar 

  7. Oczkowski SJW (2014) A clinician’s guide to the assessment and interpretation of noninferiority trials for novel therapies. Open Med 8:e67–e72

    PubMed  PubMed Central  Google Scholar 

  8. Hahn S (2012) Understanding noninferiority trials. Korean J Pediatr 55:403–407

    Article  PubMed  PubMed Central  Google Scholar 

  9. Meinert CL, Tonascia S (1986) Clinical trials: design, conduct, and analysis. Oxford University Press, Oxford

    Book  Google Scholar 

  10. Mann H, Djulbegovic B (2003) Choosing a control intervention for a randomised clinical trial. BMC Med Res Methodol 3:7

    Article  PubMed  PubMed Central  Google Scholar 

  11. Toloi D d A, Jardim DLF, Hoff PMG, Riechelmann RSP (2015) Phase I trials of antitumour agents: fundamental concepts. Ecancermedicalscience 9:501

    PubMed Central  Google Scholar 

  12. Suvarna V (2010) Phase IV of drug development. Perspect Clin Res 1:57–60

    PubMed  PubMed Central  Google Scholar 

  13. Center for Devices and Radiological Health, C. for B. E. and R (2013) Design considerations for pivotal clinical investigations for medical devices - guidance for industry. Clinical Investigators, Institutional Review Boards and Food and Drug Administration Staff, Silver Spring, MD

    Google Scholar 

  14. Comparing medical device and drug trials: how they differ - premier research. Available at: https://premier-research.com/perspectivesmedical-devices-vs-drug-trials/. Accessed: 8th November 2017

    Google Scholar 

  15. Feise RJ (2002) Do multiple outcome measures require p-value adjustment? BMC Med Res Methodol 2:8

    Article  PubMed  PubMed Central  Google Scholar 

  16. Akobeng AK (2008) Assessing the validity of clinical trials. J Pediatr Gastroenterol Nutr 47:277–282

    Article  PubMed  Google Scholar 

  17. Moher D, Schulz KF, Altman DG (2001) CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 134:657–662

    Article  CAS  PubMed  Google Scholar 

  18. Freedman B (1987) Equipoise and the ethics of clinical research. N Engl J Med 317:141–145

    Article  CAS  PubMed  Google Scholar 

  19. Portney LG, Watkins MP (2009) Foundations of clinical research: applications to practice. Pearson/Prentice Hall, Upper Saddle River, N.J.

    Google Scholar 

  20. Flannelly LT, Flannelly KJ, Jankowski KRB (2014) Independent, dependent, and other variables in healthcare and chaplaincy research. J Health Care Chaplain 20:161–170

    Article  PubMed  Google Scholar 

  21. Andrade C (2015) The primary outcome measure and its importance in clinical trials. J Clin Psychiatry 76:e1320–e1323

    Article  PubMed  Google Scholar 

  22. Freemantle N (2001) Interpreting the results of secondary end points and subgroup analyses in clinical trials: should we lock the crazy aunt in the attic? BMJ 322:989–991

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Aronson JK (2005) Biomarkers and surrogate endpoints. Br J Clin Pharmacol 59:491–494

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Krousel-Wood MA, Chambers RB, Muntner P (2006) Clinicians’ guide to statistics for medical practice and research: part I. Ochsner J 6:68–83

    PubMed  PubMed Central  Google Scholar 

  25. Whitley E, Ball J (2002) Statistics review 5: comparison of means. Crit Care 6:424–428

    Article  PubMed  PubMed Central  Google Scholar 

  26. Bewick V, Cheek L, Ball J (2004) Statistics review 9: one-way analysis of variance. Crit Care 8:130–136

    Article  PubMed  PubMed Central  Google Scholar 

  27. Motulsky H (2010) Intuitive biostatistics: a nonmathematical guide to statistical thinking. Oxford University Press, Oxford

    Google Scholar 

  28. Bewick V, Cheek L, Ball J (2003) Statistics review 7: correlation and regression. Crit Care 7:451

    Article  PubMed  PubMed Central  Google Scholar 

  29. Bewick V, Cheek L, Ball J (2004) Statistics review 12: survival analysis. Crit Care 8:389–394

    Article  PubMed  PubMed Central  Google Scholar 

  30. Röhrig B, du Prel J-B, Wachtlin D, Kwiecien R, Blettner M (2010) Sample size calculation in clinical trials: part 13 of a series on evaluation of scientific publications. Dtsch Arztebl Int 107:552–556

    PubMed  PubMed Central  Google Scholar 

  31. Kumar A, Chakraborty B (2016) Interim analysis: a rational approach of decision making in clinical trial. J Adv Pharm Technol Res 7:118

    Article  PubMed  PubMed Central  Google Scholar 

  32. Vickers AJ (2006) How to randomize. J Soc Integr Oncol 4:194–198

    Article  PubMed  PubMed Central  Google Scholar 

  33. Kang M, Ragan BG, Park J-H (2008) Issues in outcomes research: an overview of randomization techniques for clinical trials. J Athl Train 43:215–221

    Article  PubMed  PubMed Central  Google Scholar 

  34. Karanicolas PJ, Farrokhyar F, Bhandari M (2010) Blinding: who, what, when, why, how? Can J Surg 53:345–348

    PubMed  PubMed Central  Google Scholar 

  35. Kolahi J, Bang H, Park J (2009) Towards a proposal for assessment of blinding success in clinical trials: up-to-date review. Community Dent Oral Epidemiol 37:477–484

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Neuromodulation, Center of Clinical Research Learning, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, MA, USA

    Isadora Santos Ferreira, Beatriz Teixeira Costa & Felipe Fregni

  2. Spaulding Research Institute, Spaulding Rehabilitation Hospital, Harvard Medical School, Charlestown, MA, USA

    Felipe Fregni

Authors
  1. Isadora Santos Ferreira
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Beatriz Teixeira Costa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Felipe Fregni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Felipe Fregni .

Editor information

Editors and Affiliations

  1. Laboratory of Neuromodulation, Center of Clinical Research Learning, Spaulding Rehabilitation Hospital, Harvard Medical School, Boston, Massachusetts, USA

    Felipe Fregni

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Ferreira, I.S., Costa, B.T., Fregni, F. (2018). Introduction. In: Fregni, F. (eds) Clinical Trials in Neurology. Neuromethods, vol 138. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7880-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-7880-9_1

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-7879-3

  • Online ISBN: 978-1-4939-7880-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation